Prelude Therapeutics
PRLD
#9034
Rank
ยฃ53.64 M
Marketcap
ยฃ0.98
Share price
5.83%
Change (1 day)
-59.10%
Change (1 year)

EPS for Prelude Therapeutics (PRLD)

EPS in 2023 (TTM): -ยฃ1.76

According to Prelude Therapeutics's latest financial reports the company's current EPS (TTM) is -ยฃ1.67. In 2022 the company made an earnings per share (EPS) of -ยฃ1.87 a decrease over its 2021 EPS that were of -ยฃ1.86.

EPS history for Prelude Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-ยฃ1.76-5.98%
2022-ยฃ1.870.83%
2021-ยฃ1.86-61.3%
2020-ยฃ4.80

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-ยฃ1.67 0.46%๐Ÿ‡บ๐Ÿ‡ธ USA